Leishmania donovani

GPTKB entity

Statements (66)
Predicate Object
gptkbp:instance_of gptkb:species
gptkbp:affects gptkb:humans
gptkbp:associated_with malnutrition
HIV co-infection
gptkbp:cause visceral leishmaniasis
gptkbp:clinical_trial acute form
chronic form
gptkbp:communication_system sandflies
gptkbp:community_health yes
gptkbp:controls vector control
public health education
insecticide-treated nets
gptkbp:diagnosis blood tests
serological tests
PCR tests
bone marrow biopsy
gptkbp:discovered_by gptkb:William_Boog_Leishman
gptkbp:diseases macrophages
gptkbp:endemic_to gptkb:Bangladesh
gptkb:Brazil
gptkb:India
gptkb:Nepal
gptkb:Sudan
gptkbp:first_described_by 1903
gptkbp:genus gptkb:Leishmania
https://www.w3.org/2000/01/rdf-schema#label Leishmania donovani
gptkbp:is_a gptkb:Parasite
gptkbp:is_found_in tropical and subtropical regions
gptkbp:is_vulnerable_to ongoing
gptkbp:life_cycle requires a mammalian host
requires a sandfly vector
gptkbp:related_to gptkb:Leishmania_braziliensis
gptkb:Leishmania_infantum
gptkbp:research genetic studies
epidemiological studies
host-parasite interactions
pathogenesis studies
studied for vaccine development
studied for drug resistance
gptkbp:seed_dispersal haploid
32 million base pairs
gptkbp:symptoms gptkb:anemia
weight loss
fever
skin lesions
hepatomegaly
splenomegaly
gptkbp:transmission zoonotic
anthroponotic
gptkbp:treatment gptkb:immunotherapy
gptkb:miltefosine
combination therapy
supportive care
antifungal agents
antimonials
liposomal amphotericin B
gptkbp:treatment_resistance emerging issue
gptkbp:type_of gptkb:Leishmania
gptkbp:vector gptkb:Phlebotomus_sandflies
gptkbp:wildlife yes
gptkbp:bfsParent gptkb:Leishmania_spp.
gptkb:Trypanosomatida
gptkb:Euglenozoa
gptkb:Trypanosomatidae
gptkb:Leishmania
gptkbp:bfsLayer 6